The impact of the 21-gene recurrence score (Oncotype DX) on concordance of adjuvant therapy decision making as measured by the Liverpool Systemic Therapy Adjuvant Decision Tool

Collapse authors list.
Olsson-Brown, Anna, Piskilidis, Pavlos, O'Hagan, Julie, Thorp, Nicky, Robson, Peter, Innes, Helen, Wong, Helen, Cicconi, Silvia ORCID: 0000-0001-5507-6203, Jackson, Richard, Kiernan, Tamara et al (show 3 more authors) , Holcombe, Christopher, O'Reilly, Susan and Palmieri, Carlo ORCID: 0000-0001-9496-2718 (2019) The impact of the 21-gene recurrence score (Oncotype DX) on concordance of adjuvant therapy decision making as measured by the Liverpool Systemic Therapy Adjuvant Decision Tool. BREAST, 44. 94 - 100.

	Text CP FINAL Sept 2018 Olsson-Brown et al 2018.pdf - Accepted Version Download (732kB)
	Text CP FINAL complete Figures for oncotype paper.pdf - Accepted Version Download (752kB)